期刊文献+

内脏脂肪素在2型糖尿病大鼠脂肪组织中的表达及意义

Visfatin Gene in Fatty Tissue of Rats with Type 2 Diabetes Mellitus
下载PDF
导出
摘要 目的:检测实验性2型糖尿病大鼠脂肪组织中内脏脂肪素(visfatin)mRNA表达的情况,探讨visfatin与2型糖尿病相关性。方法:高糖高脂饮食喂养大鼠4周加尾静脉注射小剂量链脲佐菌素(STZ)30mg/kg复制2型糖尿病大鼠模型,继续高糖高脂饮食喂养8周后取材,测定空腹血糖(FBG)、总胆固醇(TC)、三酰甘油(TG)、血清胰岛素(FINS)并计算胰岛素抵抗指数(irt);检测内脏脂肪组织中visfatinmRNA表达水平。结果:2型糖尿病大鼠FBG、FINS、TC、TG水平、IR值升高;内脏脂肪组织中visfatin mRNA表达量明显增高并与FBG、TG、IR呈显著正相关。结论:visfatin mRNA的表达在2型糖尿病胰岛素抵抗中起重要作用。 OBJECTIVE: To observe the expression of Visfatin gene mRNA in fatty tissue of Rats (T2DM) with type 2 diabetes Mellitus and discuss the relation between visfatin and T2DM. METHODS: Wistar Rats of T2DM model were made and fed by high glucose and fat diet and injected by small dose of streptozocin (STZ) (30 mg/kg) for 4 weeks. And then high glucose and fat diet were fed to these Rats contimually for weeks. FBG, TC, TG and FINS were measured and calculate IR. Visfatin gene mRNA expres- sion in fatty tissue was determined. RESULTS: FBG, FINS, TC, TG levels and IR of T2DM rised. Visfatin gene mRNA expression increased obviously in fatty tissue of T2DM and had significantly positive correlation with FBG, TG and IR. CONCLUSION: Expres- sion of Visfatin gene mRNA play an important role in insulin resistance of T2DM.
出处 《国际老年医学杂志》 2014年第6期247-249,共3页 International Journal of Geriatrics
基金 黑龙江省教育厅科研项目(11551519)
关键词 2型糖尿病 内脏脂肪素 基因表达 T2DM Visfatin Gene expression
  • 相关文献

参考文献5

  • 1高爱滨,马建国,肖谦.visfatin与2型糖尿病[J].国外医学(老年医学分册),2008,29(5):231-233. 被引量:3
  • 2Saltiel AR,Kahn CR.Insulin signaling and the regulation of glucose and lipid metabolism[J].Nature,2001,414:799-806.
  • 3Fukuhara A,Matsuda M,Nishizawa M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insulin[J].Science,2005,307:426-430.
  • 4Kralisch S,Klein J,Lossner U,et al.Interleukin-6 is a negative regulator of visfafin gene expression in 3T3-L1 adipocytes[J].Am J Physiol Endocrinol Metab,2005,289 (4):E586-E590.
  • 5Sethi JK,Vidal-Puig A.Visfatin:the missing link between intraabdominal obesity and diabetes[J].Trends Mol Med,2005,11 (8):344-347.

二级参考文献18

  • 1Fukuhara A, Matsuda M, Nishizawa M et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science, 2005 ; 307 (5708) : 426 - 430.
  • 2Ognjanovic S, Bryant - Greenwood GD. Pre B - cell colony - enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol, 2002; 187 (4) : 1051 - 1058.
  • 3Sethi JK. Is PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome? Curr Hypertens Rep, 2007; 9 (1): 33-38.
  • 4Hutley L, Prins JB. Fat as an endocrine organ: relationship to the metabolic syndrome. Am J Med Sci, 2005; 330 (6) : 280 - 289.
  • 5Rongvaux A, Shea R J, Mulks MH et al. Pre - B - cell colony - enhancing factor, whose expression is up - regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol, 2002 ; 32 ( 11 ) : 3225 - 3234.
  • 6Haider DG, Schaller G, Kapiotis S et al. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia, 2006 ; 49 (8) : 1909 - 1914.
  • 7Chen MP, Chung FM, Chang DM et al. Elevated plasma level of visfatin/pre - B cell colony - enhancing factor in patients with type 2 diabetes meilitus. J Clin Endocrinol Metab, 2006 ; 91 ( 1 ) : 295 - 299.
  • 8Haider DG, Pleiner J, Francesconi Met al. Exercise training lowers plasma visfatinn concentrations in patients with type 1 diabetes. J Clin Endocrinol Metab, 2006 ; 91 ( 11 ) : 4702 - 4704.
  • 9Dogru T, Sonmez A, Tasci Iet al. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes meUitus and impaired glucose tolerance. Diabetes Res Clin Pract, 2007 ; 76 ( 1 ) : 24 - 29.
  • 10Lopez - Bermejo A, Chico - Julia B, Fernandez - Balsells M et al. Serum visfatin increases with progressive beta - cell deterioration. Diabetes, 2006; 55 (10): 2871-2875.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部